Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/01/19
End: 03/31/20
Due: 03/31/21
Phase: N/A
Priority: Normal
Start: 08/13/15
End: 07/31/25
Due: 07/31/26
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Omega™ Left Atrial Appendage (LAA) Occluder in Patients With Non-Valvular Atrial Fibrillation | NCT03526471 | Vascular Innovations Co. Ltd. | user2@example.com | None | 2019-06-01 | 2020-03-31 | 2021-03-31 | - | - | 2025-07-14 |
| A Clinical Evaluation of the HYDRA Self Expanding Transcatheter Aortic Valve | NCT02434263 | Vascular Innovations Co. Ltd. | user2@example.com | None | 2015-08-13 | 2025-07-31 | 2026-07-31 | - | - | 2025-07-14 |